Location History:
- Osaka, JP (1982 - 1990)
- Osaka-fu, JP (1999)
Company Filing History:
Years Active: 1982-1999
Title: Yoshiaki Ikeda: Innovator in Antitumor Agents
Introduction
Yoshiaki Ikeda is an accomplished inventor based in Osaka, Japan, renowned for his contributions to the field of pharmaceuticals. With a total of four patents to his name, Ikeda has made significant strides in developing novel compounds that hold promise in the fight against cancer.
Latest Patents
Ikeda's recent patents include a Quinazoline compound that acts as an anti-tumor agent. This compound is characterized by a specific chemical structure that contributes to its efficacy in cancer treatment. In addition, he has developed a novel platinum complex which serves as an antineoplastic agent. This innovative compound functions as an intermediate, allowing for further chemical reactions that result in potent therapeutic agents.
Career Highlights
Yoshiaki Ikeda is currently employed at Kanebo, Limited, where he leverages his expertise in developing pharmaceutical products. His work focuses on creating mechanisms that can effectively target and combat tumors, thereby contributing to advancements in cancer therapies.
Collaborations
Throughout his career, Ikeda has collaborated with colleagues such as Masanori Takamatsu and Munetaka Matsui. These partnerships have facilitated the exchange of ideas and the pooling of resources, enhancing the research and development of effective therapeutic agents.
Conclusion
With his innovative spirit and dedication to scientific advancement, Yoshiaki Ikeda continues to impact the pharmaceutical industry significantly. His patents in anti-tumor agents highlight his commitment to improving cancer treatments, making him a notable figure in modern medical research.